Plasma S100A8/A9 Heterodimer Is An Early Prognostic Marker of Acute Kidney Injury Associated with Cardiac Surgery

Zacharoula Nikolakopoulou, Lauren R. Hector, Ben Creagh‐Brown, Timothy W. Evans, Gregory J. Quinlan, Anne Burke‐Gaffney

Biomarkers in Medicine · 2019 · 20 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

AIM: We investigated whether plasma levels of the inflammation marker S100A8/A9, could predict acute kidney injury (AKI) onset in patients undergoing cardiac surgery necessitating cardiopulmonary bypass (CPB). PATIENTS & METHODS: Plasma levels of S100A8/A9 and other neutrophil cytosolic proteins were measured in 39 patients pre- and immediately post-CPB. RESULTS: All markers increased significantly post-CPB with S100A8/A9, S100A12 and myeloperoxidase levels significantly higher in patients who developed AKI within 7 days. S100A8/A9 had good prognostic utility for AKI, with an area under the receiver operating characteristic curve of 0.81 (95% CI: 0.676-0.949) and a cut-off value of 10.6 μg/ml (85.7% sensitivity and 75% specificity) irrespective of age. CONCLUSION: Plasma S100A8/A9 levels immediately after cardiac surgery, can predict onset of AKI, irrespective of age.

References

45